Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: A randomized clinical trial

Journal of Periodontal Research

Volumn 47, Issue 5, 2012, Pages 584-592

  Ozcaka O ^a,b   Basoglu O K ^a   Buduneli, N ^a   Tasbakan M S ^a   Bacakoglu F ^a   Kinane, D F ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chlorhexidine gluconate; Dental care; Intensive care units; Periodontal disease; Ventilator associated pneumonia

Indexed keywords

CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; INTENSIVE CARE; ISOLATION AND PURIFICATION; LENGTH OF STAY; LUNG; LUNG LAVAGE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MOUTH HYGIENE; PERIODONTICS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUCTION; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, TOPICAL; AGE FACTORS; ANTI-INFECTIVE AGENTS, LOCAL; APACHE; BRONCHOALVEOLAR LAVAGE; CHLORHEXIDINE; DENTAL PLAQUE INDEX; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE; LENGTH OF STAY; LUNG; MIDDLE AGED; ORAL HYGIENE; PERIODONTAL INDEX; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RISK FACTORS; SUCTION;

EID: 84865548419     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2012.01470.x     Document Type: Article

References (41)

1. Raghavendran K, Mylotte JM, Scannapieco FA. Nursing home-associated pneumonia, hospital-acquired pneumonia and ventilator-associated pneumonia: the contribution of dental biofilms and periodontal inflammation. Periodontol 2000 2007;44:164-177.
2. American Thoracic Society. Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
3. Verghese A, Berk SL. Bacterial pneumonia in the elderly. Medicine (Baltimore) 1983;62:271-285.
4. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992;20:740-745.
5. Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C. Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med 1998;26:301-308.
6. Terpenning M, Bretz W, Lopatin D, Langmore S, Dominguez B, Loesche W. Bacterial colonization of saliva and plaque in the elderly. Clin Infect Dis 1993;4:S314-S316.
7. Mojon P, Budtz-Jorgensen E, Michel JP, Limeback H. Oral health and history of respiratory tract infection in frail institutionalised elders. Gerodontology 1997;14:9-16.
8. Mandel ID. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 1988;15:488-498.
9. Wu CD, Savitt ED. Evaluation of the safety and efficacy of over-the-counter oral hygiene products for the reduction and control of plaque and gingivitis. Periodontol 2000 2002;28:91-105.
10. Lang NP, Catalanotto FA, Knopfli RU, Antczak AA. Quality-specific taste impairment following the application of chlorhexidine digluconate mouthrinses. J Clin Periodontol 1988;15:43-48.
11. Brecx M, Netuschil L, Reichert B, Schreil G. Efficacy of Listerine, Meridol and chlorhexidine mouthrinses on plaque, gingivitis and plaque bacteria vitality. J Clin Periodontol 1990;17:292-297.
12. Brecx M, Brownstone E, MacDonald L, Gelskey S, Cheang M. Efficacy of Listerine, Meridol and chlorhexidine mouthrinses as supplements to regular tooth cleaning measures. J Clin Periodontol 1992;19:202-207.
13. Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D. Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol 2001;28:1127-1136.
14. Herrera D, Roldan S, Santacruz I, Santos S, Masdevall M, Sanz M. Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol 2003;30:307-314.
15. DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-1561.
16. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000;26:1239-1247.
17. Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect 2001;2:5-18.
18. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11:567-570.
19. Koeman M, van der Ven AJ, Hak E et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006;173:1348-1355.
20. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006;296:2460-2466.
21. Lansford T, Moncure M, Carlton E et al. Efficacy of a pneumonia prevention protocol in the reduction of ventilator-associated pneumonia in trauma patients. Surg Infec 2007;8:505-510.
22. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008;29:131-136.
23. Mori H, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M. Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intensive Care Med 2006;32:230-236.
24. Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systemic review and meta-analysis. BMJ 2007;334:889.
25. Chlebicki MP, Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007;35:595-602.
26. Pineda LA, Saliba RG, El Solh AA. Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis. Crit Care 2006;10:R35.
27. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care - associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
28. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006;130:251-260.
29. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009;135:1150-1156.
30. Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM et al. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect Control Hosp Epidemiol 2009;30:952-958.
31. Kollef MH, Bock KR, Richards RD, Hearns ML. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995;122:743-748.
32. Ioanas M, Ferrer R, Angrill J, Ferrer M, Torres A. Microbial investigation in ventilator-associated pneumonia. Eur Respir J 2001;17:791-801.
33. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-597.
34. Turkish Thoracic Society. The consensus report on diagnosis and treatment hospital-acquired pneumonia in adults. Turk Toraks Derg 2009;10:3-24. (Article in Turkish)
35. Fourrier F, Dubois D, Pronnier P et al. PIRAD Study Group: effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebocontrolled multicenter study. Crit Care Med 2005;33:1728-1735.
36. Lorente L, Blot S, Rello J. Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 2007;30:1193-1207.
37. Tasbakan SM, Gurgun A, Basoglu OK, Ekren PK, Pullukcu H, Bacakoglu F. Comparison of bronchoalveolar lavage and mini-bronchoalveolar lavage in the diagnosis of pneumonia in immunocompromised patients. Respiration 2011;81:229-235.
38. Scannapieco FA, Yu J, Raghavendran K et al. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009;13:R117.
39. El-Solh AA, Pietrantoni C, Bhat A et al. Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 2004;126:1575-1582.
40. Heo SM, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin Infec Dis 2008;47:1562-1570.
41. Cronan CA, Potempa J, Travis J, Mayo JA. Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II). Oral Microbiol Immunol 2006;21:212-217.